Open-label, two-period single sequence study investigating the effect of rifampin on the pharmacokinetics of a single dose of alisporivir

Trial Profile

Open-label, two-period single sequence study investigating the effect of rifampin on the pharmacokinetics of a single dose of alisporivir

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Dec 2015

At a glance

  • Drugs Alisporivir (Primary) ; Rifampicin
  • Indications Bacterial infections; Hepatitis C
  • Focus Pharmacokinetics
  • Most Recent Events

    • 30 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top